Stem cell innovation in the USA: the benefits of the minimal state

ISSN： 1746-0751

Source： Regenerative Medicine, Vol.3, Iss.4, 2008-07, pp. : 597-610

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hematopoietic stem cell transplantation for sickle cell disease: state of the science

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 5, 2015-05 ,pp. : 391-399

John Wiley & Sons Inc

Access to resources Recommend Favorite

Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastoma

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 8, 2015-08 ,pp. : 1368-1373

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 162, Iss. 2, 2013-07 ,pp. : 147-161

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Implications of Minimal Residual Disease Monitoring for Stem Cell Transplantation after Reduced Intensity and Nonmyeloablative Conditioning

Acta Haematologica, Vol. 112, Iss. 1-2, 2004-06 ,pp. : 93-104

Karger

Access to resources Recommend Favorite

The Significance of Minimal Residual Disease in Stem Cell Grafts and the Role of Purging: Is It Better to Purge in vivo or in vitro?

Acta Haematologica, Vol. 114, Iss. 4, 2005-11 ,pp. : 206-213

Karger

Access to resources Recommend Favorite